SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is experiencing significant volatility, with community members actively discussing a potential short squeeze and comparing it to other high-flying stocks. The stock's rapid price movement has captured the attention of day traders, while some caution about its long-term sustainability due to a history of reverse splits. News surrounding a new ESG compliance technology is circulating amid the high trading volume.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amidst discussions about a potential short squeeze and speculation around upcoming catalysts, including the BFS report. Community members are debating the impact of recent developments, such as the copper powder stockpile acquisition, with some expressing concerns about dilution and transparency, while others highlight the strategic importance of securing non-Chinese supply chains. Overall, the stock's movement is tied to sentiment around rare earth miners and anticipation for key company updates.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics ($GALT) is trending amid community discussions about potential FDA feedback on its NAVIGATE data and speculation around a possible buyout before year-end, as the community is closely monitoring for news catalysts. The stock's movement is being influenced by discussions regarding trading halts, potential manipulation, and their implications for short sellers. Community members highlight CEO Joel Lewis's increased excitement and the consistency of positive biomarker data.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending after strong earnings, with revenue and EPS exceeding expectations, marking its first GAAP-profitable Q3. The community is buzzing about its potential, with many eyeing continued growth and a possible short squeeze, while also discussing its strategic partnerships and future prospects in the AI automation space. Investors are weighing in on whether this surge is sustainable and discussing price targets, with some comparing it to Palantir ($PLTR).

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is trending due to its subsidiary LCM's new supply agreement with Solvay, sparking discussions about US rare earth independence and potential government support. The community is actively debating the company's valuation and comparing it to sector peers, while also watching for news of potential government funding or deals. Bullish sentiment is building on hopes for increased production and a potential short squeeze.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies ($QCLS) is experiencing increased attention amid discussions of a potential short squeeze and news that investor Martin Shkreli has taken a position in the company. The community is actively discussing price targets, comparing it to other stocks with similar moves, and expressing bullish sentiment for continued upward momentum. Some traders are speculating about illegal naked shorting and urging others to file complaints with the SEC.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as discussions revolve around a potential short squeeze, fueled by high short interest and anticipation of upcoming news or contract announcements. The community is weighing in on share authorization and comparing BBAI to other AI and defense sector plays like Palantir, while also noting executive leadership's background in government. Technical analysis and mentions of potential catalysts are adding to the speculative buzz.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as community members discuss recent price action and potential catalysts, including rumors of an Apple chip deal and government support. Some traders are taking profits after a significant run, while others remain bullish, anticipating further upside and long-term growth driven by AI and foundry advancements. Discussions also involve potential manipulation and short squeezes amid high trading volume.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics ($SNSE) is trending due to community excitement around its low float and potential for a significant price surge, drawing comparisons to other stocks with similar setups. Discussions highlight the stock's accumulation patterns and potential breakout points, with some anticipating a rapid climb. However, some caution against chasing the stock and highlight the company's fundamentals and financial position.

Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. It also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. It operates through the following geographical segments: United States, United Kingdom, and Malta. The company was founded on May 24, 2019 and is headquartered in New York, NY.

Nukkleus Inc - Ordinary Shares - New

Nukkleus Inc

Nukkleus is trending amid news that its pending acquisition of Rimon positions it to benefit from the expansion of Israel's Iron Dome, driving speculation of a potential short squeeze. The community is closely watching for a breakout and anticipating a significant price increase, with some drawing parallels to past rallies and pointing to a special meeting in December concerning the Star 26 acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bancroft Fund Ltd. (NYSE MKT: BCV) operates as a closed-end, diversified management company and invests primarily in convertible securities with the objectives of providing income and the potential for capital appreciation; which objectives the Fund considers to be relatively equal, over the long-term, due to the nature of the securities in which it invests.

Current Price	$22.43
Prev Close	$22.21
Open	$22.33
Dividend Yield	7.63%
50-Day Moving Average	$22.68
Beta	0.63
Avg. Volume	19,914.11
PE Ratio	11.49

52-Week High	$23.88
52-Week Low	$15.63
Market Capitalization	$130.2M
EPS (Annual)	$2.11
Price to Book	1.15
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

BCV
Bancroft Fund Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest BCV News

BCVBancroft Fund Ltd.